Identification of drug target candidates of the swine pathogen Actinobacillus pleuropneumoniae by construction of protein-protein interaction network
Identification of drug target candidates of the swine pathogen Actinobacillus pleuropneumoniae by construction of protein-protein interaction network
复制标题
通过构建蛋白质-蛋白质相互作用网络鉴定猪病原体胸膜肺炎放线杆菌的候选药物靶点
DOI:
10.1007/s13258-018-0691-3
复制
发表时间:
2018
期刊:
影响因子:
2.1
通讯作者:
Rui Zhou
中科院分区:
文献类型:
--
作者:
Siqi Li;Zhipeng Su;Chengjun Zhang;Zhuofei Xu;Xiaoping Chang;Jiawen Zhu;Ran Xiao;Lu Li;Rui Zhou
Porcine pleuropneumonia caused byActinobacillus pleuropneumoniaehas led to severe economic losses in the pig industry worldwide.A. pleuropneumoniaedisplays various levels of antimicrobial resistance, leading to the dire need to identify new drug targets. Protein–protein interaction (PPI) network can aid the identification of drug targets by discovering essential proteins during the life of bacteria. The aim of this study is to identify drug target candidates ofA. pleuropneumoniaefrom essential proteins in PPI network. The homologous protein mapping method (HPM) was utilized to constructA. pleuropneumoniaePPI network. Afterwards, the subnetwork centered with H-NS was selected to verify the PPI network using bacterial two-hybrid assays. Drug target candidates were identified from the hub proteins by analyzing the topology of the network using interaction degree and homologous comparison with the pig proteome. AnA. pleuropneumoniaePPI network containing 2737 non-redundant interaction pairs among 533 proteins was constructed. These proteins were distributed in 21 COG functional categories and 28 KEGG metabolic pathways. TheA. pleuropneumoniaePPI network was scale free and the similar topological tendencies were found when compared with other bacteria PPI network. Furthermore, 56.3% of the H-NS subnetwork interactions were validated. 57 highly connected proteins (hub proteins) were identified from theA. pleuropneumoniaePPI network. Finally, 9 potential drug targets were identified from the hub proteins, with no homologs in swine. This study provides drug target candidates, which are promising for further investigations to explore lead compounds againstA. pleuropneumoniae.